Day Before Bharat Biotech’s Meet with WHO, Covaxin’s Phase 3 Trial Data to be Reviewed by Expert Panel

June 22, 2021

The phase 3 trial data will clearly state the efficacy of the Covid-19 vaccine. Bharat Biotech, the developers of Covaxin, had already been in the dock for delay in announcing its trial data.

Previous articleMonday Milestone EXPLAINED | How India’s Vaccine Numbers Shot up, Will Feat Fortify Against 3rd Wave?

Next articleNews18 Daybreak | As PM Modi Sets the Ball Rolling, What Is in Store for J&K?; Bitcoin Drops to Two-Week Low; Ether Slumps Over 10%

Day Before Bharat Biotech’s Meet with WHO, Covaxin’s Phase 3 Trial Data to be Reviewed by Expert Panel

Similar Articles

Most Popular

Day Before Bharat Biotech’s Meet with WHO, Covaxin’s Phase 3 Trial Data to be Reviewed by Expert Panel

Similar Articles

Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims

Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms

Most Popular

AMPC reforms: BJP digs out Siddaramaiah’s old letter

India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts

Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films